| Literature DB >> 29636885 |
Long Li1,2,3, Hongyan Yin1, Yan Zhao1, Xiaofang Zhang1, Chaoli Duan1, Jing Liu1, Caoxin Huang1, Suhuan Liu1, Shuyu Yang1, Xuejun Li1.
Abstract
Acute liver injury is a destructive liver disorder resulting from overwhelming liver inflammation, oxidative stress and hepatocyte death. Puerarin is a natural flavonoid compound isolated from the traditional Chinese herb radix puerariae. This study investigated the protective effects of puerarin against lipopolysaccharide (LPS)/D-galactosamine (D-Gal)-induced liver injury and the potential mechanisms in mice. Mice were given an intraperitoneal administration of puerarin 200 mg/kg 2 h prior to LPS (50 μg/kg)/D-Gal (400 mg/kg) injection and were sacrificed 6 h post LPS/D-Gal treatment. The results showed that administration of puerarin substantially alleviated LPS/D-Gal-induced acute liver injury in mice by increased survival rates, improved liver histopathology, reduced plasma alanine aminotransferase (ALT) and aspartate aminotransferase (AST) levels, alleviated production of pro-inflammatory cytokines, and suppressed hepatocyte apoptosis. Moreover, puerarin pretreatment activated autophagy by increased the ratio of LC3B-II/I and the protein levels of Beclin-1, decreased the levels of p62 protein expression. Taken together, these findings demonstrated that puerarin could prevent the LPS/D-Gal-induced liver injury in mice, and its mechanisms might be associated with the increments of autophagy and suppression of apoptosis.Entities:
Keywords: Puerarin; acute liver injury; apoptosis; autophagy; lipopolysaccharide (LPS)
Year: 2018 PMID: 29636885 PMCID: PMC5883136
Source DB: PubMed Journal: Am J Transl Res ISSN: 1943-8141 Impact factor: 4.060